WASHINGTON — U.S. Sen Brian Schatz has become a vocal advocate for expanding research into therapeutic use of psychedelic drugs such as ketamine, MDMA, LSD and psilocybin to treat depression, anxiety, addiction and post-traumatic stress disorder. “For me, this isn’t about whether psychedelics should be legalized for recreational purposes,” Schatz said. “This is about continuing … Continue reading US Sen. Brian Schatz’s Subtle Push For More Psychedelic Research